 |
 |
|||
 |
 |
 |
 |
|
|
 |
Possible Class Action Lawsuit against VioxxAug-19-05 - Recently a jury awarded $253.4 million in damages to a man who died of arrhythmia or irregular heartbeat, after approximately eight months of Vioxx use. This, despite the fact that the manufacturer claims it studied whether Vioxx caused arrhythmias in nine clinical trials before the drug went on the market, and determined that there was “no clinically meaningful differences" in patients who took the pain killer versus a placebo or other NSAID medication.Nevertheless, counsel for the deceased victim’s wife and plaintiff, stated that her husband died too quickly for his heart to show damage. He also pointed to Merck’s own highly recognized medical reference, The Merck Manual, which itself states that arrhythmias play a role in more than ninety percent of all heart attacks. If you consulted a lawyer who declined your case due to lack of myocardial infarction, or you completed a form on this site that indicated a rhythm disorder and you did not receive a response from an attorney, please submit your complaint to us and clearly note your arrythmia issue. Jul-02-03 - Vioxx (Rofecoxib) is a Cox-2 inhibitor that was approved by the US Food and Drug Administration in 1999 for the treatment of arthritis, osteoarthritis, menstrual pain and for the management of acute pain in adults. Serious concerns have been raised in recent months regarding the use of Vioxx, Vioxx side effects on kidney and cardiovascular health, and the increased risk of heart attack and stroke. Vioxx is an anti-inflammatory drug, which means it reduces internal inflammation. Vioxx, along with Aspirin, is part of the class of drugs known as nonsteroidal anti-inflammatory drugs (NSAID) - i.e. it is not a steroid. Vioxx is analgesic, (it eliminates pain) and it is antipyretic (it reduces fevers). Its active ingredient is rofecoxib. Vioxx withdrawn from the market Vioxx was pulled off the shelves worldwide in September 2004 after a clinical study confirmed concerns that it raises the risk of heart attack and stroke, which can lead to serious and permanent injuries and death. More than 2 million people worldwide are using Vioxx.Complications begin approximately 18 months after patients start taking Vioxx. Previous clinical trials had linked Vioxx to an increase in blood clots and other cardiovascular problems, including heart attack, chest pain related to heart disease, stroke and sudden death. Vioxx users were more than twice as likely to experience heart problems than patients using the control drug. The results of clinical studies with one drug in a given class do not necessarily apply to other drugs in the same class. All NSAIDs have some risks, such as gastrointestinal (stomach) bleeding, and liver and kidney toxicity, when taken chronically. Vioxx advisory from FDA Doctors are being told to take patients off Vioxx. Please talk to your Doctor as soon as possible about switching to another drug. The FDA has issued a public health advisory, and plans to work closely with Merck to coordinate the withdrawal of Vioxx from the US market.FDA Public Health Advisory The FDA public health advisory on Vioxx safety. [US FDA]Vioxx In the News Judge denies mistrial request by Merck lawyers in second Vioxx lawsuit claiming that Vioxx caused a New Jersey man's heart attack in 2001. (Oct-03-05) [CNN]Due to hurricane Katrina federal Vioxx cases are being moved from New Orleans to Houston. (Sep-06-05) [TALLAHASSEE DEMOCRAT] New Jersey Vioxx trial is set. (Aug-30-05) [REUTERS] Jury Awards Widow $253.4 million in Vioxx Trial (Aug-19-05) [BUSINESS WEEK] Merck Vioxx Suit Certified as Class Action by New Jersey Judge [BLOOMBERG] Internal documents show that Merck considered reformulating Vioxx in 2000 to reduce cardiovascular side effects after a study found patients were five times more likely to have heart attacks than those on the generic naproxen. (June-23-05) [SAN FRANCISCO CHRONICLE] LEGAL NOTICE AND
DISCLAIMER: The materials
within this web site are for informational purposes only. They
are not legal advice and should not be used as such. Transmission
of the information in this web site is not intended to create,
and receipt does not constitute, an attorney-client relationship.
Internet users and readers should not act upon this information
without first seeking professional legal counsel. The information
in this web site is provided only as general information which
may or may not reflect the most current legal developments. Past
results do not guarantee the outcome of future cases. PLEASE
CLICK HERE FOR FULL WEBSITE TERMS OF USE, IMPORTANT ADVERTISING
DISCLAIMERS AND PRIVACY INFORMATION. |
|
|
|||
|
|||||||
